You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

PRAVASTATIN SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pravastatin Sodium patents expire, and what generic alternatives are available?

Pravastatin Sodium is a drug marketed by Accord Hlthcare, Apnar Pharma Lp, Apotex, Aurobindo Pharma, Biocon Pharma, Chartwell Rx, Cipla, Dr Reddys Labs Inc, Glenmark Generics, Hisun Pharm Hangzhou, Mylan, Mylan Pharms Inc, Pliva Hrvatska Doo, Ranbaxy Labs Ltd, Teva, Teva Pharms, Watson Labs, and Zydus Pharms Usa. and is included in eighteen NDAs.

The generic ingredient in PRAVASTATIN SODIUM is pravastatin sodium. There are sixteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pravastatin Sodium

A generic version of PRAVASTATIN SODIUM was approved as pravastatin sodium by TEVA on April 24th, 2006.

  Try a Trial

Drug patent expirations by year for PRAVASTATIN SODIUM
Drug Prices for PRAVASTATIN SODIUM

See drug prices for PRAVASTATIN SODIUM

Drug Sales Revenue Trends for PRAVASTATIN SODIUM

See drug sales revenues for PRAVASTATIN SODIUM

Recent Clinical Trials for PRAVASTATIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Maryland, BaltimorePhase 4
University of ThessalyN/A
University of Southern CaliforniaPhase 2

See all PRAVASTATIN SODIUM clinical trials

Pharmacology for PRAVASTATIN SODIUM
Medical Subject Heading (MeSH) Categories for PRAVASTATIN SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for PRAVASTATIN SODIUM
Paragraph IV (Patent) Challenges for PRAVASTATIN SODIUM
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PRAVACHOL Tablets pravastatin sodium 30 mg 019898 1 2005-06-01

US Patents and Regulatory Information for PRAVASTATIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 077013-002 Oct 23, 2006 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Dr Reddys Labs Inc PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 076714-004 Dec 28, 2007 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pliva Hrvatska Doo PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 077730-002 Nov 21, 2006 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 076939-004 Oct 23, 2006 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Pharms Inc PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 079187-002 May 27, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pliva Hrvatska Doo PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 077730-003 Nov 21, 2006 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ranbaxy Labs Ltd PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 076445-004 Apr 23, 2007 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.